<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>NYSTOP- nystatin powder </strong><br>Paddock Laboratories, LLC<br></p></div>
<h1>
<span class="Bold">Nystop</span><span class="Bold">®</span><br>Nystatin Topical Powder, USP<br><span class="Bold">Rx Only</span><br>For topical use only.<br>Not for ophthalmic use.</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ID_8abdcc4f-8d35-415a-936c-5a501b6de0ac"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Nystatin is a polyene antifungal antibiotic obtained from <span class="Italics">Streptomyces </span><span class="Italics">nursei</span><span class="Italics">. </span>The molecular formula for Nystatin is C<span class="Sub">47</span>H<span class="Sub">75</span>NO<span class="Sub">17</span>. The molecular weight of Nystatin is 926.1.</p>
<p>Structural formula:</p>
<div class="Figure">
<a name="id2023823057"></a><img alt="Structural Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e1b4622c-0f9f-4c00-b42c-2aa85a5e3d4f&amp;name=233f198b-cf3d-41ed-8094-60315dc46919-01.jpg">
</div>
<p>Nystatin Topical Powder USP is for dermatologic use.</p>
<p>Nystatin Topical Powder USP contains 100,000 USP nystatin units per gram dispersed in talc.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="ID_71e186a3-9e74-4c76-9073-9151ff8138df"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="43682-4">
<a name="ID_a0610ccf-3d43-4922-9264-b2a1be53fc1d"></a><a name="section-2.1"></a><p></p>
<h2>Pharmacokinetics</h2>
<p class="First">Nystatin is not absorbed from intact skin or mucous membrane.</p>
</div>
<div class="Section" data-sectionCode="49489-8">
<a name="ID_78c2877a-0699-4089-85b1-a81fbd5b97d9"></a><a name="section-2.2"></a><p></p>
<h2>Microbiology</h2>
<p class="First">Nystatin is an antibiotic which is both fungistatic and fungicidal <span class="Italics">in vitro </span>against a wide variety of yeasts and yeast-like fungi, including <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> </span><span class="Italics">albicans</span><span class="Italics">, C. </span><span class="Italics">parapsilosis</span><span class="Italics">, C. </span><span class="Italics">tropicalis</span><span class="Italics">, C. </span><span class="Italics">guilliermondi</span><span class="Italics">, C. </span><span class="Italics">pseudotropicalis</span><span class="Italics">, C. </span><span class="Italics">krusei</span><span class="Italics">, </span><span class="Italics">Torulopsis</span><span class="Italics"></span><span class="Italics">glabrata</span><span class="Italics">, </span><span class="Italics">Tricophyton</span><span class="Italics"></span><span class="Italics">rubrum</span><span class="Italics">, T. </span><span class="Italics">mentagrophytes</span><span class="Italics">.</span></p>
<p>Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> </span><span class="Italics">albicans</span><span class="Italics"></span>does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> (C, </span><span class="Italics">tropicalis</span><span class="Italics">, C. </span><span class="Italics">guillier</span><span class="Italics"></span><span class="Italics">mondi</span><span class="Italics">, C. </span><span class="Italics">krusei</span><span class="Italics">, </span>and <span class="Italics">C. </span><span class="Italics">stellatoides</span><span class="Italics">) </span>become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="ID_3e8da09f-8556-45d3-958c-e94317431e5d"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Nystatin Topical Powder is indicated in the treatment of cutaneous or mucocutaneous mycotic <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span> caused by <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> </span><span class="Italics">albicans</span><span class="Italics"></span>and other susceptible <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> </span>species.</p>
<p><span class="Bold">This preparation is not indicated for systemic, oral, </span><span class="Bold">intravaginal</span><span class="Bold"> or ophthalmic use.</span></p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="ID_9c2f6f4e-a10e-4f7b-a104-c3a638c91f87"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Nystatin Topical Powder is contraindicated in patients with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to <span class="Bold">any </span>of its components.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_a6836717-7f71-4919-aa8b-6a8ac93c5fb0"></a><a name="section-5"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="gen"></a><a name="section-5.1"></a><p></p>
<h2>General</h2>
<p class="First"><span class="Bold">Nystatin</span><span class="Bold"> Topical Powder should not be used for the treatment of systemic, oral, </span><span class="Bold">intravaginal</span><span class="Bold"> or ophthalmic <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>.</span></p>
<p>If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or <span class="product-label-link" type="condition" conceptid="4104522" conceptname="Mucocutaneous candidiasis">mucocutaneous candidiasis</span> and to rule out <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> caused by other pathogens.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="ID_e016f984-54cf-4a1c-a61b-9051bede5742"></a><a name="section-5.2"></a><p></p>
<h2>INFORMATION FOR THE PATIENT</h2>
<p class="First">Patients using this medication should receive the following information and instructions:</p>
<dl>
<dt>1.</dt>
<dd>The patient should be instructed to use this medication as directed (including the replacement of missed doses). This medication is not for any disorder other than that for which it is prescribed.</dd>
<dt>2.</dt>
<dd>Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed.</dd>
<dt>3.</dt>
<dd>If symptoms of irritation develop, the patient should be advised to notify the physician promptly.</dd>
</dl>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="ID_8895aeb6-8236-4272-9d03-0a37e4e6da47"></a><a name="section-5.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">If there is a lack of therapeutic response, KOH smears, cultures, or other diagnostic methods should be repeated.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="ID_16bd51ee-baf9-4a24-b7a3-413fb402618d"></a><a name="section-5.4"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed to determine the mutagenicity of nystatin or its effects on male or female fertility.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="ID_223c7fb8-561e-43bf-a42d-6c281a026c08"></a><a name="section-5.5"></a><p></p>
<h2>Pregnancy:</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="ID_87195f97-1e3e-470b-a824-1e07764cc9ad"></a><a name="section-5.5.1"></a><p></p>
<h3><span class="Bold">Teratogenic Effects</span></h3>
<p class="First">Category C. Animal reproduction studies have not been conducted with any nystatin topical preparation. It also is not known whether these preparations can cause fetal harm when used by a pregnant woman or can affect reproductive capacity. Nystatin topical preparations should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="ID_695335f3-0a26-4345-9f73-d4dc6661c9d8"></a><a name="section-5.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether nystatin is excreted in human milk. Caution should be exercised when nystatin is prescribed for a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="ID_b30a7e65-ac16-47ab-846e-8e916f5fad8c"></a><a name="section-5.7"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness have been established in the pediatric population from birth to 16 years. (See <span class="Bold">DOSAGE AND ADMINISTRATION</span>).</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="ID_16ddf438-bf73-4d1e-bb16-a26367b41359"></a><a name="section-6"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">The frequency of adverse events reported in patients using nystatin topical preparations is less than 0.1%. The more common events that were reported include <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>, burning, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span>, and <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> on application. (See <span class="Bold">PRECAUTIONS: General</span>.)</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="dosage"></a><a name="section-7"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Very moist lesions are best treated with the topical dusting powder.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_02eddb0a-f3a1-4c40-80e1-c91d1080ef0b"></a><a name="section-7.1"></a><p></p>
<h2>Adults and Pediatric Patients (Neonates and Older):</h2>
<p class="First">Apply to candidal lesions two or three times daily until healing is complete. For <span class="product-label-link" type="condition" conceptid="432248" conceptname="Opportunistic mycosis">fungal infection</span> of the feet caused by <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> </span>species, the powder should be dusted on the feet, as well as, in all foot wear.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="ID_ab0b9452-c6e8-46f8-a302-066d0a11af32"></a><a name="section-8"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Nystop<span class="Sup">® </span>Nystatin Topical Powder USP is supplied as 100,000 units nystatin per gram in 15 g, 30 g and 60 g plastic squeeze bottles.</p>
<p>(NDC 0574-2008-15)</p>
<p>(NDC 0574-2008-30)</p>
<p>(NDC 0574-2008-02)</p>
<div class="Section" data-sectionCode="44425-7">
<a name="ID_c801bbee-c115-4c65-b3ad-827b9e647a73"></a><a name="section-8.1"></a><p></p>
<h2>STORAGE</h2>
<p class="First">Store at controlled room temperature 15°-30°C (59°-86°F); avoid excessive heat (40°C; 104°F).</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_f6899aa2-a569-4332-b166-20a84460f222"></a><a name="section-9"></a><p></p>
<p class="First">Manufactured By Perrigo</p>
<p>Minneapolis, MN 55427</p>
<p>2122653</p>
<p>(09-12)</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_c4c69df2-1a0b-410a-9094-6dcb0ec587fa"></a><a name="section-10"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL- 60 grams label</h1>
<p class="First">Rx Only</p>
<p>NDC 0574-2008-02</p>
<p>NYSTOP®</p>
<p>Nystatin Topical Powder, USP</p>
<p>100,000 USP Units Per Gram</p>
<p>USUAL DOSAGE:  Apply to affected area 2 or 3 times daily.</p>
<p>STORAGE:  Store at controlled room temperature 15° - 30°C (59° - 86°); avoid excessive heat (40°C; 104°F).</p>
<p>Net Weight</p>
<p>60 grams</p>
<div class="Figure">
<a name="id-2066556098"></a><img alt="Perrigo Nystop - 60 gram label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e1b4622c-0f9f-4c00-b42c-2aa85a5e3d4f&amp;name=233f198b-cf3d-41ed-8094-60315dc46919-02.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NYSTOP 		
					</strong><br><span class="contentTableReg">nystatin powder</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0574-2008</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Nystatin</strong> (Nystatin) </td>
<td class="formItem">Nystatin</td>
<td class="formItem">100000 [USP'U]  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>Talc</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0574-2008-15</td>
<td class="formItem">15 g in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0574-2008-30</td>
<td class="formItem">30 g in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:0574-2008-02</td>
<td class="formItem">60 g in 1 BOTTLE, PLASTIC; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA064118</td>
<td class="formItem">08/16/1996</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Paddock Laboratories, LLC
							(967694121)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>L. Perrigo Company (006013346)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Paddock Laboratories, LLC.</td>
<td class="formItem"></td>
<td class="formItem">967694121</td>
<td class="formItem">MANUFACTURE(0574-2008)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>233f198b-cf3d-41ed-8094-60315dc46919</div>
<div>Set id: e1b4622c-0f9f-4c00-b42c-2aa85a5e3d4f</div>
<div>Version: 6</div>
<div>Effective Time: 20140917</div>
</div>
</div> <div class="DistributorName">Paddock Laboratories, LLC</div></p>
</body></html>
